INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "CRYSTALLINE FORMS OF ZONGERTINIB A HER2 TYROSINE KINASE INHIBITOR"

GENEVA, Dec. 22 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 INGELHEIM AM RHEIN) filed a patent application (PCT/EP2025/066061) for "CRYSTALLINE FORMS OF ZONGERTINIB A HER2 TYROSINE KINASE INHIBITOR" on Jun 10, 2025. With publication no. WO/2025/257149, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MULDER, Jason Alan (c/o VP, IP, LegalBoehringer Ingelheim USA Corp.900 Ridgebury Road, P.O. Box 368Ridgefield, Connecticut 06877-0368), AYOUB, Ghada (Eurofins CDMO Alphora Inc.2395 Speakman DriveMississ...